Fuelled by the obesity epidemic, there is considerable interest in the developmental origins of white adipose tissue (WAT) and the stem and progenitor cells from which it arises. Whereas increased visceral fat mass is associated with metabolic dysfunction, increased subcutaneous WAT is protective. There are six visceral fat depots: perirenal, gonadal, epicardial, retroperitoneal, omental and mesenteric, and it is a subject of much debate whether these have a common developmental origin and whether this differs from that for subcutaneous WAT.
Here we show that all six visceral WAT depots receive a significant contribution from cells expressing Wt1 late in gestation. Conversely, no subcutaneous WAT or brown adipose tissue arises from Wt1-expressing cells. Postnatally, a subset of visceral WAT continues to arise from Wt1-expressing cells, consistent with the finding that Wt1 marks a proportion of cell populations enriched in WAT progenitors. We show that all visceral fat depots have a mesothelial layer like the visceral organs with which they are associated, and provide several lines of evidence that Wt1-expressing mesothelium can produce adipocytes. These results reveal a major ontogenetic difference between visceral and subcutaneous WAT, and pinpoint the lateral plate mesoderm as a major source of visceral WAT. They also support the notion that visceral WAT progenitors are heterogeneous, and suggest that mesothelium is a source of adipocytes.
Although there has been much progress recently in identifying adult WAT progenitors [1] [2] [3] [4] [5] , the embryological origins of different WAT depots remain obscure. In a recent review this was highlighted as one of the big unanswered questions in the field 6 . Transcriptomic analysis of pre-adipocytes isolated from the stromal vascular fraction (SVF) of fat has revealed consistent differences in developmental gene expression between visceral depots and between visceral and subcutaneous fat [7] [8] [9] . However, in one study of human depots it was concluded that pre-adipocytes of mesenteric WAT had an expression profile closer to that of subcutaneous than omental pre-adipocytes. Similarly, transcriptome analysis of mouse adipose depots showed that the expression of some developmental genes was high in subcutaneous and perirenal WAT, but low in mesenteric WAT. It has been posited, from these and other similar studies, that each WAT depot could be considered a separate mini-organ. It was not possible to infer either a common or distinct origin for subcutaneous and visceral WAT or the different WAT depots.
The Wilms' tumour gene, Wt1, is a major regulator of mesenchymal progenitors in the developing kidney and heart 10, 11 . During development Wt1 expression is restricted mainly to the intermediate mesoderm, parts of the lateral plate mesoderm and tissues that derive from these including kidney, gonads, peri-/epicardium, spleen, mesentery, omentum and the mesothelial layer that lines the visceral organs and the body cavity (peritoneum). There is a striking relationship between these Wt1-expressing tissues and the location of the six visceral fat depots. Recently we showed that Wt1 is expressed in several visceral fat depots, but not in subcutaneous WAT or brown adipose tissue 12 (BAT) . These observations led us to reason that some visceral fat may arise from Wt1-expressing cells during development. To investigate this, we carried out cell lineage analysis.
Before carrying out lineage analysis, it was first necessary to demonstrate that Wt1 is not itself expressed in adipocytes. Adipose tissue is composed of a mixed population of cells, including the mature adipocytes and the SVF. We isolated adipose depots from Wt1-green fluorescent protein (GFP) knock-in mice and separated the tissues into mature adipocytes (floating) and the SVF by centrifugation. We showed that the Wt1-positive cells are not present in the floating mature adipocytes ( Fig. 1a-d ) but they were abundant in the SVF from epididymal, mesenteric, retroperitoneal, omental, epicardial and perirenal WAT ( Fig. 1e-l) . We stained the floating layer with a lipid dye (LipidTox) and showed that all cells in this layer are LipidTox positive ( Supplementary Fig. 1a ). Wt1-positive cells were not found in the SVF obtained from subcutaneous WAT or BAT ( Fig. 1e-l) . We showed previously by quantitative PCR (qPCR) that Wt1 messenger RNA is expressed in all of the visceral fat depots analysed, including epididymal, mesenteric and retroperitoneal WAT. Our fluorescenceactivated cell sorting (FACS) analysis reinforces these findings and also revealed Wt1-expressing cells in omental, epicardial and perirenal WAT. We also analysed WT1 expression in human adipose samples. As for mice, expression was observed in visceral (omental) WAT but levels were very low or undetectable in whole subcutaneous adipose tissue, and in subclavicular subcutaneous adipose enriched for BAT (confirmed by high levels of UCP-1 expression compared with neighbouring white adipose tissues (an approximately 1,687-fold increase of UCP-1 in the BAT; Supplementary Table 1 and Fig. 1m ,n).
For cell lineage analysis, knock-in mice expressing tamoxifeninducible Cre recombinase at the Wt1 promoter locus as described were crossed with the reporter;mTmG mice 13 . Before Cre-mediated recombination, Tomato is expressed ubiquitously under a pCA promoter. After Cre-mediated loxP recombination that excises Tomato, membranous GFP is expressed. Thus, this system allows genetic marking of CreER-expressing cells at the time of tamoxifen injection (driven by Wt1 promoter activity), and the subsequent tracing of these cells and their progeny. To determine whether adipose tissues may arise from Wt1-expressing cells during development, maternal injection of tamoxifen was performed at embryonic day (E)14.5 (one dose) and the tissues were analysed when the mice were 1.2 years old (n = 4). Approximately 77% of mature adipocytes were Wt1-positive lineage positive in the epididymal fat ( Fig. 2a,b) . Similarly, large numbers of adipocytes were positive in all visceral fat pads analysed including epicardial (66%), omental (47%), mesenteric (28%), retroperitoneal and perirenal fat depots ( Supplementary Fig. 2 ). However, there were no positive adipocytes derived from Wt1expressing cells in the subcutaneous WAT and BAT ( Fig. 2c,d ).
We were interested in determining whether the subcutaneous and visceral fat have different origins and when the separation might take place. During development, Wt1 is first expressed at E8.5 in the intermediate and lateral plate mesoderm in mice 14 . By E14.5, the formation of the body cavity has already taken place. To determine whether cells that are positive for Wt1 expression during E8.5-E14.5 can contribute to the subcutaneous or BAT adipo-lineages, we used a constitutively active Wt1 Cre ;R26RYFP model 15 . No adipocytes that arise from Wt1-expressing cells were detected in subcutaneous WAT ( Fig. 2f ), whereas as expected adipocytes in visceral WAT that derived from Wt1-expressing cells were seen ( Fig. 2e ).
To determine whether any visceral fat may arise from Wt1expressing cells postnatally during the growth phase, we induced the Cre by oral administration of tamoxifen to three-week-old Wt1 CreERT2 ; mTmG mice (n = 3). GFP expression in adipose tissues was analysed when mice were three months old. Membranous GFP signals were detected (while negative for endogenous Wt1) in epididymal fat pads using an anti-GFP antibody ( Fig. 2g , indicated in red). A GFP signal was detected in some cells with mono-ocular lipid vacuoles, characteristic of mature adipocytes. Sections were co-stained with anti-perilipin antibody (an adipocyte marker, indicated in green) to verify that the GFP-positive cells are adipocytes ( Fig. 2h ). No GFP signals were detected in the subcutaneous or BAT fat pads ( Fig. 2i,j) . To show that the absence of GFP signal was not due to the fixing method, we were able to stain the subcutaneous fat depot with an anti-red fluorescent protein (RFP) antibody ( Supplementary Fig. 2f ). In addition, we also investigated whether any Wt1-positive cells contributed to adipocytes in bone marrow. Surprisingly, we did not detect any Wt1-positive cells in the bone marrow when mice were induced at embryonic stage (E14.5) or adult ( Supplementary Fig. 1b,c) .
Given the contribution of juvenile and adult Wt1-expressing cells to mature visceral adipocytes we next examined whether Wt1positive cells express the cell surface marker sets that characterize progenitors. Recently, two cell populations with the properties of adipocyte progenitors and pre-adipocytes have been isolated by FACS (refs 1,4); these are Lin − CD29 + CD34 + Sca1 + CD24 + and Lin − CD29 + CD34 + Sca1 + CD24 − populations, respectively ( Fig. 3a ). In subcutaneous WAT it was shown that the CD24negative pre-adipocyte population arises from the CD24-positive progenitor population and there is a shift from the latter to the former after birth 4 . We show that most of the Lin − Wt1 + cells in the adult adipose depots are in the Lin − CD31 − CD29 + CD34 + population (Fig. 3b ,c, ∼90%). In addition, most of the Lin − Wt1 + cells are in the Lin − CD31 − CD29 + CD34 + Sca1 + CD24 − population (from 60 to 90% depending on fat pad, Fig. 3c ); and a smaller percentage of the Lin − CD31 − Wt1 + cells is in the Lin − CD31 − CD29 + CD34 + Sca1 + CD24 + population, the highest level being in the omentum (Fig. 3c ). Figure 3d shows the percentage of cells in each population that are Wt1 positive. Epicardial and omental fat have the highest percentage of cells that are Wt1-positive in both the Lin − CD31 − CD29 + CD34 + Sca1 + CD24 − (60% and 40% respectively) and the Lin − CD31 − CD29 + CD34 + Sca1 + CD24 + (20% and 40% respectively) populations. Both omental and epicardial fat pads are particularly implicated in human disease risk 16, 17 . We demonstrated that the Wt1-positive cells in the SVF are capable of differentiating to adipocytes and muscle in vitro ( Supplementary Fig.  3a ,b). They have limited ability to form osteoblasts ( Supplementary  Fig. 3c ). Interestingly, we also noticed a difference in the osteoblastforming ability of SVFs between different fat pads ( Supplementary  Fig. 3d ). SVFs from mesenteric, subcutaneous and epicardial fat pads have a stronger ability to differentiate to osteoblasts compared with SVFs from epididymal and omental fat pads.
To determine whether Wt1 has a role in regulating the behaviour of adipose progenitors, we deleted Wt1 using a ubiquitous tamoxifen-inducible model. In this model, one allele of the Wt1 locus is floxed by loxP sites and the other allele is a GFP knock-in that disrupts Wt1 function (CAGG CreERT2 ; Wt1 loxp/GFP ). We performed the deletion in 3-week-old mice and collected the tissues 7 days after the first dose of tamoxifen (n = 4 for each group). We saw a trend of reduction in the percentage of GFP cells in the Lin − CD31 − CD29 + CD34 + Sca1 + CD24 − population in all fat pads analysed; however, the difference was statistically significant only in epididymal (P = 0.015, Fig. 3e ) and omental fat (P = 0.042, Fig. 3e ), but not in the mesenteric and epicardial fat ( Fig. 3e ). Although there was a reduction in the percentage of Lin − CD31 − CD29 + CD34 + Sca1 + CD24 + cells that were GFP positive in the epididymal and epicardial fat, this was not statistically significant. As for other visceral organs that are covered by a layer of Wt1expressing mesothelium, the visceral adipose depots were also found to be lined by a GFP-positive mesothelium. Figure 2k shows epididymal fat at 6.5 months following tamoxifen induction at 4 months where GFP is indicated in red and the adipocyte marker perilipin is marked in green. This mesothelial layer still expressed endogenous Wt1 and GFP 1.2 years after being induced at E14.5 ( Fig. 2l ). We also observed a Wt1-positive and cytokeratin-positive mesothelial layer in the other visceral fat depots ( Supplementary  Fig. 4a ). The importance of the mesothelium as a source of mesenchymal progenitors for interstitial cells/structures during development has been demonstrated in the heart, lung, gut and liver 10, 15, [18] [19] [20] [21] [22] [23] . Furthermore, the peritoneum and its extensions, the mesentery and omentum, are essentially mesothelial structures that develop fat depots. Therefore, we reasoned that the mesothelium might be able to contribute to the adipocytes that often physically attach to the visceral organs. Consistent with this idea, in the lineage tracing model, a short pulse of tamoxifen (induced at E14.5 and analysed at E16.5) labelled only mesothelial cells at the site where future fat pads will be formed ( Supplementary Fig. 4b ). Before postnatal day 4, adipocytes are not yet formed in the thin, translucent membrane-like structure adjacent to the testes that later becomes the epididymal fat pad 24 . The authors of ref. 24 developed an ex vivo culture system for this epididymal appendage and showed that it can produce adipocytes, following the normal time course of fat production in vivo. Furthermore, they showed that if this structure was removed in vivo, epididymal fat was no longer produced. We reasoned that this structure looks very similar to a mesothelium and hence it would express Wt1. Therefore, we cultured this layer to see whether it expresses Wt1, a major marker for the mesothelium, and to determine whether Wt1-expressing cells contribute to mature adipocytes. Using pups from the Wt1 CreERT2 ;mTmG line, this layer of 'mesothelium' was dissected from postnatal day 3 pups and cultured ex vivo in medium containing 4-OH tamoxifen and adipogenic medium. Time-lapse video analysis showed that all cells in the mesothelium expressed RFP at the beginning and no GFP signals were detected. After 5.5-9.5 h, many cells expressed GFP and some of these started to migrate out from the mesothelium ( Supplementary Video 1) .
No GFP cells were detected in the Cre-negative mesothelium from the Wt1 CreERT2 ;mTmG pups (Supplementary Video 2). After 110 h, some cells that migrated out started to produce lipid droplets. The mesothelial nature of the epididymal appendage was confirmed by immunohistochemistry using mesothelin antibody ( Supplementary  Fig. 5a ). Wt1-GFP embryo stained with the mesothelin antibody was used as a positive control ( Supplementary Fig. 5b ).
We then used multiphoton microscopy to further characterize the lipid-droplet-containing cells in the centre of the explant culture. Lipid droplets generate strong coherent anti-Stokes Raman scattering (CARS) signals (indicated in red). The explant was imaged on day 1, day 7 and day 14 after culturing with adipogenesis medium. It is clearly seen that there are Wt1-derived cells from the epididymal appendage (that is, cells with membranous GFP signal) that are capable of generating lipid containing adipocytes (Fig. 4a ). We confirmed that the lipid-droplet-filled cells were adipocytes by staining with FABP4 and perilipin antibodies ( Supplementary Fig.  5c,d) . The results obtained from both the explant culture system and in vivo lineage tracing in adult mice show there are Wt1-derived and non-Wt1-derived adipocytes. We were interested in this heterogeneity and in determining whether the Wt1-derived adipocytes (that is GFP positive) differ from the other adipocytes (RFP positive). In the ex vivo system (Fig. 4b) , preliminary results suggested that Wt1-lineage adipocytes had fewer but larger lipid droplets per cell compared with RFP-positive adipocytes. Similarly, in the in vivo epididymal fat there were fewer droplets in the GFP-positive cells than the RFP-positive cells but there was no significant difference in droplet size. The cell size and percentage of lipid content did not differ between GFP-positive or RFP-positive adipocytes either in the ex vivo or in vivo systems (Fig. 4d ).
We reasoned that mesothelium might be a source of visceral adipocytes and hence we investigated whether mesothelium during development shares the cell surface marker expression pattern of adipose progenitors and pre-adipocytes seen in the adult fat pads. FACS analysis was carried out on GFP-positive mesothelial cells removed by gentle collagenase treatment (Fig. 5b) . We chose E14.5 as a starting point as this is the stage at which embryos were induced in the previous lineage tracing analysis (Fig. 2) . At E14.5, the mesothelium from Wt1-GFP embryos is Lin − CD31 − CD34 + CD29 + CD24 + Sca1 − . The expression pattern remains unchanged at E15.5 and E16.5. There is an emergence of Lin − CD31 − CD34 + CD29 + CD24 + Sca1 + population of cells at E17.5. At postnatal day (P)1 and P7, there was a reduction in cells with CD24-positive expression and the population of Sca1-positive cells increased. In adult, most cells are Lin − CD31 − CD34 + CD29 + Sca1 + CD24 − (Fig. 5a ). Hence, the mesothelium expresses cell surface markers characteristic of WAT progenitors and pre-adipocytes and there is a gradual shift in the pattern that broadly resembles that described for subcutaneous WAT (ref. 4) .
To confirm the mesothelial nature of the cells used for the FACS analysis, we used qPCR to measure the mRNA levels of two validated mesothelial markers, Msln and Upk3b (ref. 25 ), in E14.5 and adult preparations. The levels of Msln and Upk3b mRNA were approximately two orders of magnitude higher in the GFP-positive cells than in the GFP-negative cells from the collagenase-treated layer at both E14.5 and adult stages ( Supplementary Table 2a ). Importantly, the GFP-positive cells after a brief pulse of tamoxifen in the lineage tracing system, and GFP-positive cells isolated from the epididymal appendage used for explant showed similar absolute levels of mesothelial marker mRNA expression to the validated mesothelia taken at E14. 5 Table 2b ,c).
and adult (Supplementary
One major conclusion from this study is that visceral and subcutaneous WAT, the so-called bad and good fat, have different origins during development. At least 30-80% (depending on the depot) of visceral adipocytes in 14-month-old mice have arisen from cells that express Wt1 between E14.5-16.5 (the likely duration of action of tamoxifen). Given that only a single dose of tamoxifen has been administered, Cre-mediated recombination is unlikely to be complete and some fat progenitors will arise outside this time frame, these percentages are likely to be underestimates. Taken together, these data suggest that Wt1 marks true long-term adipocyte progenitors late in gestation. We find no contribution of Wt1-expressing cells to subcutaneous WAT or BAT during embryogenesis or in postnatal life in the fat pads analysed. This conclusion is also supported by experiments using a constitutive Wt1 Cre for the lineage analysis. The question arises as to the exact location and nature of the Wt1expressing adipose progenitors/pre-adipocytes. Over the past few years, it has become evident that the mesothelium is an abundant source of mesenchymal cells that contribute to a variety of tissues and cell types 10, 15, [18] [19] [20] [21] [22] [23] . Here we provide evidence that the mesothelium is a source for at least some visceral WAT progenitors/pre-adipocytes. First, we show that visceral WAT has a Wt1-expressing mesothelial layer. Second, in the region where visceral fat will form a short pulse of tamoxifen at E14.5 in the lineage tracing model predominantly labels mesothelial cells as revealed by immunohistochemistry and qPCR on sorted cells. Third, using an ex vivo culture system, we show that an epididymal mesothelial appendage can produce adipocytes from Wt1-expressing cells. Finally, Wt1-positive mesothelial cells express cell surface markers characteristic of WAT progenitors late in gestation and this shifts postnatally to a cell surface marker pattern characteristic of pre-adipocytes, thus approximating a scenario reported for subcutaneous WAT (ref. 4) . The mesothelium has its origins in the lateral plate mesoderm and we propose that this is the source of some adipose progenitors in all visceral WAT depots. Some visceral WAT may also arise from Wt1-expressing cells derived Supplementary Table 5 .
from the intermediate mesoderm. BAT has been shown to arise from paraxial mesoderm and, consistent with these different mesodermal origins, we find no contribution of Wt1-expressing cells to the BAT lineage. This leaves open the question of the developmental origins of subcutaneous fat. It seems reasonable to propose that the source will be outside the peritoneum. The diagram in Fig. 5c explains these conclusions and speculations. A second conclusion from the lineage tracing is that Wt1 contributes to a subset of adipocytes and that the proportion varies between visceral depots. Support for this idea of progenitor Wt1 expression is also found in septum transversum, which contributes to gut mesenteries, hepatic sinusoids, peri/epicardium, ventricular myocardium (see note above) and diaphragm. At E14.5, Wt1 is expressed in the developing kidney, gonads, adrenal glands, spleen, omentum, mesenteries, the mesothelial layer of all visceral organs (including epicardium and pericardium), and the peritoneum, as well as mesenchyme located near these tissues; the mesothelium and mesenchyme are represented in green. In the adult, we found Wt1 expression in all of the visceral fat pads including omentum (1), retroperitoneal (2), perirenal (3), mesenteric (4), epididymal (5) in the abdominal cavity, and epicardial (6) in the thoracic cavity. Its expression is not detected in the subcutaneous (7) and BAT (8) , which are both outside the body cavity. It has been shown previously that the myf5positive population of cells in the paraxial mesoderm contributes to BAT as well as retroperitoneal WAT (ref. 26 ). The origin of subcutaneous WAT (7) is not known.
heterogeneity comes from a previous study 26 that showed that 50% of retroperitoneal fat arises from myf5-expressing cells but at most only a few per cent of epididymal adipocytes arise from this source. This is in agreement with our demonstration that most epididymal fat arises from Wt1-positive progenitors, whereas fewer than 50% of retroperitoneal adipocytes derive from Wt1-positive progenitors.
In the adult, most Wt1-positive cells in the SVF express markers characteristic of pre-adipocytes. The proportion of pre-adipoctyes expressing Wt1 varies from 10 to 60% between depots, again supporting the idea of heterogeneity. Similarly, depending on the depot, Wt1-positive cells comprise 4-40% of the adult progenitor population, being most abundant in omental and epicardial fat. All of this raises the interesting question of whether the adipocytes arising from Wt1-positive progenitors/pre-adipocytes have different properties from the adipocytes arising from the Wt1-progenitors/preadipocytes. Our first experiments to address this issue using multiphoton microscopy on in vivo and ex vivo epididymal fat suggest that the adipocytes arising from Wt1 progenitors/pre-adipocytes have fewer droplets. More work will be required to determine whether the Wt1-derived adipocytes have different metabolic properties from the non-Wt1-derived adipocytes. Our preliminary data suggest that Wt1 is not only a marker for visceral fat progenitors but may also function in their regulation. More work will be needed in mice and in culture to investigate this and the mechanisms involved.
Mice and tamoxifen-induced lineage tracing. Mice were housed and bred in animal facilities at the MRC HGU, University of Edinburgh, and the University of Nice. Animals were kept in compliance with Home Office regulations. The tamoxifen-inducible lineage tracing model was made by crossing Wt1 CreERT2 with the mTmG reporter line 13 . The tamoxifen-induced Wt1 deletion model, where one copy of the Wt1 locus is a GFP knock-in and the other allele (exon 1) is flanked by loxP sites, was made in our group ([CAGG CreERT2 -positive, Wt1 loxp/loxp ]). Wt1-GFP knock-in mice used in this study were provided by H. Sugiyama 27 (Osaka University School of Medicine, Japan). The constitutively active Wt1 Cre line used in this study was described previously 28, 29 . The crosses of the Wt1 Cre ;R26ReYFP were made in the University of Malaga.
To induce lineage tracing in adult mice, tamoxifen was gavaged to animals at 8 mg per 40 g body weight twice per week for two consecutive weeks. Tamoxifen dosing at E14.5 was performed by maternal gavaging at 8 mg per 40 g body weight for one dose. Fostering of pups from maternally tamoxifen-dosed females is required.
Mice used in this study were adult (aged between 2 and 10 months if not specified). Male mice were used in the experiments unless otherwise indicated.
Human subjects. Human subcutaneous (abdominal) and visceral (omental)
adipose biopsies were obtained from patients undergoing abdominal surgery. Paired brown and white adipose tissue samples were obtained from the superficial (WAT) and deeper (BAT) supraclavicular region from euthyroid patients undergoing elective thyroid or parathyroid surgery. Ethical committee approval and written informed consent were obtained.
RNA extraction. RNA from adipose tissue was extracted using TriZol following the manufacturer's protocol.
Quantitative PCR. The same protocol is described in ref. 12 . The primer sequence and corresponding Roche Universal Probe are listed in Supplementary Table 3 .
Immunohistochemistry. The same protocol for immunostaining is described in ref. 12 . All primary antibodies were applied overnight at 4 • C. Secondary antibodies are purchased from Molecular Probes. The antibodies used are listed in Supplementary Table 4 .
FACS analysis. Adipose tissue was made into a single-cell suspension by dissecting
into small pieces (∼1-2 mm 3 ) before being digested using collagenase (2 mg ml −1 , Invitrogen) in HBSS (containing 4 mg ml −1 BSA) for one hour at 37 • C. The cell suspension was allowed to stand for 5 min before centrifuging at 1,200g for 5 min. Stromal vascular fraction (SVF) was resuspended in PBS (5% FCS) and filtered (40 µm) before being stained for surface antibodies. Antibodies are from eBioscience unless otherwise stated. The list of antibodies is included in the Supplementary Methods. For multicolour analysis and sorting, colour compensation samples were produced by singly staining SVF cells with one antibody of each of the combined fluorochromes as well as by Fluorochrome Minus One controls. FACS analysis and sorting were performed using a FACS flow cytometer and data were analysed using FlowJo and FACSDiva (BD) software.
FACS analysis on floating mature adipocytes. Mature adipocytes from fat pads of male adult mice were separated from the SVFs by collagenase digestion followed by passing through 70-100 µm filters. After centrifugation, mature adipocytes floated on the top layer were collected. Adipocytes were fixed with 0.01% PFA for 10 min, followed by a PBS wash, and staining with adipocyte marker (LipidTox Deep Red, Invitrogen) dissolved in 0.5% saporin (in PBS containing 5% FCS) for 30 min (room temperature). Adipocytes were washed and centrifuged again. Excess fluid was removed using a syringe and needle by withdrawing liquid from the bottom of the tube without disturbing the floating layer.
Characterizing adipose progenitor FACS profile in adipose tissues deleted for Wt1. To induce Cre-mediated deletion of Wt1, 3-week-old female WGER mice (CAGG CreERT2 .Wt1 loxp/GFP ) were administered with tamoxifen (4 mg per 40 g body weight, intraperitoneally, one dose daily for five consecutive days). On day 7, adipose tissues were dissected and SVF cells were stained with adipose progenitor markers. Sex-matched CAG Cre -negative littermates (CAGG +/+ .Wt1 loxp/GFP also injected with tamoxifen) were included as the negative controls.
Epididymal appendage ex vivo culture and time-lapse microscopy. The epididymal appendage adjacent to the testes from postnatal 3-day-old pups (Wt1 CreERT2 ;mTmG) was dissected under the light microscope. Mesothelium was cultured under Matrigel (serum reduced, phenol-red free) and DMEM (10% FCS and penicillin/streptomycin) containing 4-OH tamoxifen (1 µM) and adipogenesis differentiation medium. The expression of RFP and GFP, and the formation of lipid droplets were observed under fluorescence and bright-field microscopes. Images were taken every 30 min for 10 days using the Nikon Live Cell Imaging system. This comprises a motorized Nikon Eclipse TiE fluorescence microscope with a Perfect Focus System, a NikonIntensilight 130 W mercury source with a liquid light guide, excitation and emission filter wheels (Sutter Instrument), and a Photometrics Coolsnap HQ2 CCD (charge-coupled device) camera (Roper Scientific). The filter wheels were populated with a no. 89000ET sedat quad set and a no. 89021ET GFP/mCherry dual filter block (Chroma Technology). For livecell work, the system is equipped with a Solent Scientific incubation chamber with CO 2 enrichment (Solent Scientific). Image capture was performed using Nikon NIS-Elements software (Nikon Instruments).
Multiphoton/CARS microscopy. Two-photon fluorescence and coherent anti-Stokes Raman scattering (CARS) images were acquired using a custom-built multimodal microscope set-up. Briefly, a picoEmerald (APE) laser provided both a tunable pump laser (720-990 nm, 7 ps, 80 MHz repetition rate) and a spatially and temporally overlapped Stokes laser (1,064 nm, 5-6 ps, 80 MHz repetition rate). The output beams were inserted into the scanning unit of an Olympus FV1000MPE microscope using a series of dielectric mirrors and a ×4 beam-expanding module. The resulting 4.6 mm beams were expanded by a further ×3.6 within the microscope and the 16.5 mm beams directed into an Olympus XLPL25XWMP NA 1.05 objective lens using a short-pass 690 nm dichroic mirror (Olympus). Backscattered emission signals from two-photon fluorescence and CARS were separated from any backscattered excitation beams using a short-pass 690 nm dichroic mirror and an infrared cut filter (Olympus), directed into a detection unit using a reflective mirror mounted at 45 • . A series of filters and dichroic mirrors were then used to deconvolve the different emission signals onto one of four available photomultiplier tubes. GFP two-photon fluorescence signals were filtered using the following series of filters: FF552-Di02, FF483/639-Di01 and FF01-510/84-25 (Semrock). tdTomato two-photon fluorescence and CARS signals were filtered using the following series of filters: FF552-Di02, FF01-770/SP, FF705-Di01-25x36 FF01-609/181-25 (Semrock). CARS images were taken with the pump beam set to 817 nm and the Stokes beam on probing the CH2 stretch at 2, 850 cm −1 . CARS signals at the settings used were free from any fluorescence, which was confirmed by desynchronizing the lasers or blocking either the pump or Stokes beam. tdTomato images were taken with either only the Stokes beam, or with the pump and Stokes lasers temporally desynchronized removing any CARS signal on the same channel. GFP images could be collected when the pump beam was on with no bleed-through from the other imaging modes.
Laser powers after the objective were measured up to 27 mW for the pump laser and up to 21 mW for the Stokes laser. Images were recorded at 512 × 512 or 1,024 × 1,024 pixels with a pixel dwell time between 4 and 12 µs by FV10-ASW software (Olympus). Image analysis was performed in ImageJ and statistical analysis in Graphpad Prism.
The quantification involved in the characterization of lipid droplets in the ex vivo explant system and in vivo samples was based on scans from one experiment. In the explant system, 48 GFP cells and 43 tdTomato cells were counted for lipid droplet number per cell and droplet diameter analysis. Eleven GFP and eleven tdTomato cells were measured to determine cell size and percentage of lipid content. In the in vivo sample, 20 GFP cells and 22 tdTomato cells were counted for lipid droplet number per cell and droplet diameter measurement.
FACS analysis in mesothelia. Internal organs (excluding liver and thymus) from
Wt1-GFP mice were dissected out and incubated with collagenase at 37 • C for 10-15 min depending on the developmental stages. Cells were filtered through 70 µm sieves followed by a wash with PBS containing 5% FCS to inactivate the collagenase. Cells were centrifuged and used for FACS analysis and sorting. To collect mesothelium from adult male mice, individual organs were dissected and treated with collagenase. The rest of the procedure for collecting cells was the same as for cells collected from embryonic stages.
In vitro myogenic, osteogenic and adipogenic differentiation. SVF cells from fat pads of Wt1 CreERT2 .mTmG mice were cultured in DMEM (10% FCS) before plating out for differentiation. For myogenic differentiation, SVF cells were expanded in DMEM (10% FCS and 1 µM 4-OH tamoxifen). Later, C2C12 myoblasts were cocultured with SVF cells to induce differentiation (DMEM containing 3% FCS and 1 µM 4-OH tamoxifen) for two weeks. Wt1-lineaged myotubes were visualized by immunostaining of GFP and desmin antibodies. For osteogenic differentiation, SVF cells from fat pads of Wt1 CreERT2 .mTmG mice were expanded in DMEM (10% FCS and 1 µM 4-OH tamoxifen) before sorting using a panel of adipose progenitor surface markers. Sorted cells were cultured in osteoblast differentiation medium for three weeks before being assayed with alkaline phosphatase activity (Sigma). The same number of SVFs that were not stained with any fat progenitor markers were also sorted and acted as a control. For adipogenesis, SVFs were expanded in DMEM (10% FCS, penicillin/streptomycin and 1 µM 4-OH tamoxifen) before changing to adipogenesis differentiation medium. Fat pads from both male and female adult mice were used.
Statistical analysis.
All results are expressed as mean ± s.e.m. Student's t-test was used to determine P values. Statistical significance was defined as P < 0.05. No statistical method was used to predetermine sample size. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. Representative images showing reproducible results were used based on experiments performed using more than three animals in each repeated experiment, unless otherwise stated.
